Our Team

Each Partner brings extensive industry knowledge, unrivaled relationships and substantial deal experience, resulting in a team of the industry's most sought after advisors

Najeeb Ali

Najeeb Ali is a founding member of the MedTech practice at Centerview Partners. He has 20 years of experience as a strategic advisor to healthcare companies across medical device, life sciences/diagnostics, specialty pharma, and services sectors. Over the course of his career, Mr. Ali has engaged with clients on a broad range of complex strategic transactions, spin-offs and carve-outs, buy-side and sell-side mergers and acquisitions, divestitures, debt and equity financings, and partnerships.

Medical Device and LS/Dx – Strategic advisor to Illumina including financial advisor on its proxy fight with Carl Icahn; Advised ZimVie on the sale of its spine business to HIG Capital; Teleflex on its acquisition of Palette Life Sciences; BK Medical on its $1.5 billion sale to GE; Wright Medical on its $5.4 billion sale to Stryker; Zimmer Biomet on its spin-off of ZimVie; Danaher on its carve-out IPO and split-off of Envista; Becton Dickinson on its $3.0 billion mandatory preferred equity raise; Envista on its $600 million acquisition of Carestream Dental’s intra-oral scanner business from Clayton, Dubilier & Rice and $455 million sale of its KaVo business to Planmeca; Enovis (formerly Colfax) on its $3.2 billion acquisition of DJO Global from Blackstone; and Covidien on its spin-off of Mallinckrodt.

Specialty Pharma – Advised Amneal on its $6.4 billion merger with Impax Labs; Altaris Capital on its $1.6 billion acquisition of Padagis, formerly Perrigo’s generic prescription pharmaceuticals division; Par Pharmaceuticals on its $1.9 billion sale to TPG and subsequent $8.1 billion sale to Endo International; and Gavis Pharmaceuticals on its $880 million sale to Lupin.

Healthcare Services – Cardinal Health on its $1.0 billion sale of Cordis business to Hellman & Friedman; Blackstone, Carlyle, and Hellman & Friedman on its $34 billion acquisition of Medline Industries; and PharMEDium on its $2.6 billion sale to AmerisourceBergen.

Prior to joining Centerview in 2022, Mr. Ali spent 18 years at J.P. Morgan, most recently as a Managing Director within its Healthcare business.

Mr. Ali received his Bachelor of Science and a Master of Business Administration in Finance from Kelley School of Business at Indiana University Bloomington.

Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

Centerview is honored to partner with leading charitable organizations in active support of our charities:

  • Arts Connection
  • NY Cares
  • Bottomless Closet
Dupont (E. I. du Pont de Nemours and Company)
Announced: Q2 2024
Status: Pending

Financial advisor to DuPont on its separation into three independent, publicly-traded companies
View All
New York

Centerview Partners LLC

31 West 52nd Street

22nd Floor

New York, New York 10019

(212) 380-2650 | Tel
(212) 380-2651 | Fax

Centerview Partners UK LLP

1 Sherwood Street

6th Floor

London W1F 7BL

02074099700 | Tel
02074099704 | Fax

Centerview Partners France SCS

51 Avenue Hoche

Paris 75008

0180200620 | Tel
0180200621 | Fax
Menlo Park

Centerview Partners LLC

1302 El Camino Real

Suite 350

Menlo Park, California 94025

(650) 822-5800 | Tel
(650) 822-5801 | Fax
San Francisco

Centerview Partners LLC

555 California Street

Suite 4300

San Francisco, California 94104

(415) 400-0900 | Tel
(415) 400-0901 | Fax

Copyright © 2008 - 2024 Centerview Partners Holdings LP. All Rights Reserved. | Privacy and Other Notices

Centerview Partners LLC, member SIPC